Fig. 3From: Cancer stem cells as key drivers of tumour progressionSummary of key CSC-associated phenotypes via modulation of drug metabolism, acquisition of EMT and metabolic reprogramming involving signalling pathways regulation in response to different types of chemotherapeutics, conferring CSC the resistance propertiesBack to article page